| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Cytoplasmic ribosomal proteins 0.4630429745812805 3.4370417856635496 0.0005881048669023 0.3015205352068552 0.1195813229368023 75 P62266,P83881,P62753,P62917,P46782,P42766,P62701,P51812,P60866,P63173,P39023,P35268,P08708,P62857,P27635,Q9Y3U8,P62750,P62277,P62269,P62847,P46778,P61927,P61254,P18621,Q15418,P47914,P62899,P63220,P46779,P61513,P62841,P18077,P61247,P83731,P62244,Q02543,Q02878,P62854,P25398,P46776,P62241,P49207,P36578,P62910,P84098,P15880,P61313 47 |
| Dna repair pathways full network 0.5135028328742365 3.2749368140975768 0.0010568560915278 0.4753495901602821 0.1611705539579951 59 O94782,P27695,Q9NR33,P49916,Q9NVI1,P35244,P40938,Q13535,P29372,Q9BX63,P43246,Q9UQ84,Q14191,O14757,P20585,Q92889,P09429,P52701,P18858,P28340,P38398,Q9Y620,P18074,Q8TAF3 24 |
| Brainderived neurotrophic factor bdnf signaling pathway 0.5335648235852347 3.1490229790255135 0.0016381731336143 0.6321591870565239 0.193494967399645 47 Q04206,P62753,Q16539,P51812,Q14012,Q06124,P49815,P19174,P42224,Q00535,Q15418,P40763,O15111,Q13501,Q96S59,P67809,P42574,O14920,P49841,P54646 20 |
| Retinoblastoma gene in cancer 0.5032427076327626 3.016190346684257 0.0025597251629014 0.7905843372346149 0.193494967399645 54 Q14527,Q14566,P35244,P11802,P40938,O95347,Q99728,Q9NQW6,P26358,O95067,O14757,Q16204,P26583,P27707,P52701,P33981,P23921,Q13309,P14635,Q00534,P25205,P04818,P06400 23 |
| Dna damage response 0.6129080267055191 2.9951686463556597 0.0027429313979503 0.8127830319462964 0.193494967399645 26 O14757,P42574,P30307,Q86UE8,Q7LG56,Q00535,P11802,O95067,P14635,Q00534 10 |
| Cell cycle 0.4864349382338968 2.956952916937583 0.0031069555654328 0.850160899698523 0.193494967399645 58 Q99741,O14757,Q13485,O43683,P33981,Q14674,P25205,P30307,P49841,Q14566,Q12834,P11802,O95067,Q00534,P14635,Q9UBD5,P06400,Q9UJX3 18 |
| Mirna regulation of dna damage response 0.5937890963558968 2.9060929127728357 0.0036597276043379 0.8931713235846124 0.193494967399645 27 O14757,P42574,P30307,Q86UE8,Q7LG56,Q00535,P11802,O95067,P14635,Q00534 10 |
| Insulin signaling 0.4853841187553963 2.760819145587446 0.0057656594568282 0.9706138108868374 0.193494967399645 51 Q16539,P51812,P22681,O14654,P11166,Q9H4M9,Q06124,P46734,Q96PE3,P49815,Q9Y496,Q15418,O43318,O14733,O60343,Q6ZWJ1,O14920,P49841,P54646 19 |
| Tcell antigen receptor tcr pathway during staphylococcus aureus infection 0.6491079570350655 2.7228737274673436 0.0064716788530263 0.9809474377324716 0.193494967399645 18 O15111,O14733,O14920,P49841,P22681,P11802,P19174,Q9UHD1 8 |
| Atm signaling in development and disease 0.5820269897018898 2.719119495550812 0.0065455956519573 0.981792803004392 0.193494967399645 25 O14757,Q5UIP0,O43683,Q00535,O75150,Q15257 6 |
| Tolllike receptor signaling pathway 0.652857563162997 2.6868009982192795 0.0072139917941862 0.9879233864207236 0.193494967399645 17 Q04206,O15111,O14733,O14920,Q16539,Q13546,P46734,P51617,P42224 9 |
| Dna irdouble strand breaks and cellular response via atm 0.5714726074252373 2.686541202525518 0.0072196043342589 0.9879649613400115 0.193494967399645 26 O14757,Q5UIP0,P42574,P30307,Q00535,Q00613,Q9UQ84 7 |
| Leptin signaling pathway 0.5413856938844974 2.66877174270152 0.0076129167501499 0.9905491082820782 0.193494967399645 30 P40763,Q04206,O15111,P62753,O14920,Q16539,Q06124,P49841,P54646,P19174,P42224,Q15418 12 |
| Ranklrank signaling pathway 0.594739806438079 2.6437802185709915 0.0081985871666996 0.993407034636678 0.2000455268674711 22 O15111,O14733,Q13501,O14920,Q16539,P22681,P19174,P42224,O95340 9 |
| Angiopoietinlike protein 8 regulatory pathway 0.4952692590338352 2.5498214028486874 0.0107778115836771 0.9986533710460118 0.2186399996808382 34 O14654,O43318,P11166,O14733,P06730,Q16539,P49841,P51812,P46734,P54646,P22681,P49815,Q15418 13 |
| Novel intracellular components of rigilike receptor rlr pathway 0.6387030242744609 2.5448820618259407 0.0109314652282279 0.9987751148076424 0.2186399996808382 16 Q04206,O15111,O43318,Q13526,Q86UT6,O14920,Q16539,Q13546,Q12933 9 |
| Il1 signaling pathway 0.6189316053574199 2.529617654118239 0.0114186883237406 0.9990930952141316 0.2186399996808382 18 Q04206,O15111,O14733,Q13501,O14920,Q16539,Q06124,P46734,P51617,P19174 10 |
| Head and neck squamous cell carcinoma 0.6060878726768519 2.5065970512216884 0.0121899588012872 0.9994366266945992 0.2186399996808382 19 Q04206,P62753,Q13485,Q14145,P54646,Q04721,P49815,P11802,Q00534,Q13618,P06400 11 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.8246483324993186 2.4781415858072635 0.0132068725572616 0.9996994402210668 0.2186399996808382 7 P48506,O15111,Q14145,O14920 4 |
| Pentose phosphate metabolism 0.8731124652388347 2.4697543553500645 0.0135205860166289 0.9997524309674868 0.2186399996808382 6 O95336 1 |
| Interleukin1 il1 structural pathway 0.6201310045446659 2.4291493959114447 0.0151342946667976 0.9999088033131304 0.2186399996808382 16 Q04206,O43318,O14733,P27361,O15111,O14920,Q9BUB5,Q16539,P06730,P46734,P51617,Q02750,P49137 13 |
| Base excision repair 0.5938519548239207 2.4250687719833905 0.0153054870491728 0.9999179788387612 0.2186399996808382 19 P27695,Q9NR33,P49916,P29372,P09429,P18858 6 |
| Hostpathogen interaction of human coronaviruses interferon induction 0.7591439727260767 2.4231459121874885 0.0153867451102458 0.9999220055759171 0.2186399996808382 9 O15111,O14920,Q16539,Q13546,P42224 5 |
| Measles virus infection 0.5242467413681438 2.4166097597548664 0.0156658023381379 0.9999343900220788 0.2186399996808382 28 P40763,Q04206,O15111,P42574,O14920,P51617,P11802,P42224,Q00534 9 |
| Apoptosis 0.5934169595260339 2.363045626063611 0.0181254379333102 0.9999857384970702 0.2186399996808382 18 Q04206,O15111,P42574,O14920,O00221,Q99590,Q13546,O76075,Q9NRZ9,Q12933,P98170 11 |
| Hostpathogen interaction of human coronaviruses autophagy 0.8802126588327972 2.3395769843011136 0.0193055923371083 0.9999931521182424 0.2186399996808382 5 Q9NT62 1 |
| Il4 signaling pathway 0.6608400994132281 2.3363763789380365 0.0194716339303362 0.999993824119959 0.2186399996808382 12 Q04206,O15111,O14920,Q16539,Q06124,P22681,P42224 7 |
| Vitamin d in inflammatory diseases 0.7920729094891545 2.330969961436992 0.0197549436691406 0.9999948222267504 0.2186399996808382 7 O15111,Q13485,O14920,Q16539,P46734 5 |
| Pyrimidine metabolism and related diseases 0.7043813863327919 2.3180935576892363 0.0204442369662414 0.999996628756874 0.2187892026211801 10 O76075,P04818,Q7LG56,P23921 4 |
| Intraflagellar transport proteins binding to dynein 0.7352150008313875 2.3057528479713807 0.0211244462899704 0.999997793192713 0.2221709006358961 9 P63167,Q96EX3,Q8NCM8,Q9Y6G9 4 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.5977032905948358 2.2874670747302774 0.022168575116261 0.999998849109433 0.2271716037472826 16 Q04206,O15111,P42574,O14920,Q16539,Q13546,P49841,Q12933 8 |
| Integrated cancer pathway 0.5795057435675317 2.271007993686905 0.0231464940443073 0.9999993748875944 0.2277316349520562 18 O14757,P42574,Q9BX63,P52701,P43246,P11802,P42224,Q99728,P06400,P38398 10 |
| B cell receptor signaling pathway 0.5194844370333078 2.24436778045195 0.0248087477710441 0.9999997788046 0.2312289428920283 25 Q04206,O15111,O14920,Q16539,Q06124,P49841,P22681,P19174,Q15418,Q9UDY8 10 |
| Neurodegeneration with brain iron accumulation nbia subtypes pathway 0.6161613665308997 2.2274060465591874 0.0259201486812896 0.9999998896730332 0.2312289428920283 14 Q9NT62,Q96B36,O95352 3 |
| Hepatitis b infection 0.4520821607875058 2.226063144195019 0.0260099521821604 0.9999998957066124 0.2312289428920283 35 P40763,Q04206,O15111,O14733,Q13485,P42574,O14920,Q16539,P46734,P51617,Q9Y277,P42224 12 |
| Purine metabolism and related disorders 0.5861625359877961 2.213747985037525 0.0268461200113336 0.999999938237296 0.2312289428920283 16 P30520,P31153,P30566,Q7LG56,P00813,P00492,Q06203,P22102,P20839,O15067,P00491 11 |
| G1 to s cell cycle control 0.4931227438657454 2.212241335212004 0.026949994168524 0.9999999421308172 0.2312289428920283 29 Q14566,P35244,P49643,P11802,Q14181,P14635,P25205,Q9UBD5,Q00534 9 |
| Dna mismatch repair 0.5516442801880801 2.1983911501480833 0.027921243812256 0.9999999685307916 0.2333145030887147 20 Q9NR33,P52701,P18858,P43246,P35244,P40938,Q9UQ84 7 |
| Nrf2 pathway 0.5059991233560454 2.1391334873279204 0.0324248590178761 0.999999998147884 0.2528595488136624 25 Q14145,Q13501,Q16881,P48507,P48506 5 |
| Dna irdamage and cellular response via atr 0.4379718191420579 2.1301175708793156 0.033161908041136 0.9999999988364392 0.2528595488136624 41 O94782,O14757,Q92547,P30307,Q9BX63,P43246,Q9UQ84,Q99728,Q14191,P38398 10 |
| Hostpathogen interaction of human coronaviruses mapk signaling 0.6936573860967944 2.098161241057241 0.0358909041885686 0.999999999792523 0.2702895253707023 9 O14733,Q16539,P51812,P46734,Q15418 5 |
| Monoamine transport 0.8812860676009783 2.0782421599855825 0.0376870607745847 0.9999999999334792 0.2766553193438605 4 Q16539,O15127,P30307 3 |
| Nucleotide metabolism 0.6030112880532716 2.072664572307978 0.0382035070379322 0.9999999999520548 0.2766553193438605 13 P30520,P23921,Q7LG56,P00492,P28340,P31350,P20839,P19623 8 |
| P38 mapk signaling pathway 0.599519980427279 2.051853794703915 0.0401838734451511 0.9999999999863634 0.281748997718876 13 Q9BUB5,Q16539,Q8IW41,Q13546,P42224 5 |
| Bdnftrkb signaling 0.6498106124440084 2.029765210129855 0.0423804108480103 0.9999999999966293 0.2937733024691627 10 Q9BUB5,Q15418,Q15334,P19174 4 |
| Autophagy 0.6153861130084013 2.0131598516407783 0.0440978153958391 0.9999999999988722 0.3022434538366502 11 Q96B36,Q7Z3C6,P54646,Q9NT62,O95352 5 |
| Ebsteinbarr virus lmp1 signaling 0.6994307490058465 2.0078855870968937 0.0446554511041048 0.99999999999921 0.302664724150044 8 P51617,Q04206,O15111,O14920 4 |
| Mirnas involvement in the immune response in sepsis 0.7199566077532625 1.9962443436536657 0.0459073328705503 0.999999999999645 0.304923174125892 7 Q04206,O15111,O14920,Q16539,P51617 5 |
| Atr signaling 0.7971354219127527 1.99045790171946 0.0465405170287416 0.9999999999997632 0.304923174125892 5 Q92547 1 |
| Signal transduction through il1r 0.6722477876968938 1.9894064382617185 0.0466563595861135 0.9999999999997802 0.304923174125892 9 Q04206,O15111,O14920,Q16539,P46734,P51617 6 |
| Small cell lung cancer 0.5506682496651673 1.9836562264762296 0.047294176519955 0.9999999999998538 0.304923174125892 16 O15111,P42574,O14920,P11802,Q00534,Q12933,P06400 7 |
| Sting pathway in kawasakilike disease and covid19 0.7584665184405922 1.9713825789660664 0.0486801321776484 0.9999999999999398 0.304923174125892 6 Q04206,O15111,O00221,O14920 4 |
| Tolllike receptor signaling related to myd88 0.75604313233609 1.960559918014428 0.0499303819222596 0.999999999999973 0.304923174125892 6 P51617,O15111,O14920 3 |
| Oxidative damage response 0.7096440650686526 1.947398082632424 0.0514870277622407 0.99999999999999 0.304923174125892 7 O00221,P42574,O95429 3 |
| Tcell receptor tcr signaling pathway 0.4960167018519648 1.9241617101648203 0.0543343169390233 0.9999999999999984 0.3181355830189942 22 Q04206,O15111,O14920,Q16539,Q06124,P22681,P19174,Q9UDY8 8 |
| Nad biosynthetic pathways 0.8424072003338203 1.9207673613378016 0.0547610429786793 0.9999999999999988 0.3181355830189942 4 P43490 1 |
| Biomarkers for pyrimidine metabolism disorders 0.6573129729877017 1.9128371359723 0.0557689054053547 0.9999999999999992 0.3209342669553433 9 Q7LG56,P23921 2 |
| Modulators of tcr signaling and t cell activation 0.5479559102007479 1.8829577798643389 0.0597060898624133 1.0 0.3310974074188375 15 Q04206,O15111,O14920,Q15366,Q93034,P19174,Q9UDY8 7 |
| Sulfation biotransformation reaction 0.829024799582294 1.8660472210926935 0.0620347591725782 1.0 0.3380681741189062 4 P00390,O95340 2 |
| Canonical nfkb pathway 0.8246771090958838 1.8482154435898075 0.0645711821653565 1.0 0.3395553544902368 4 O15111,O00221,O14920 3 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.6644252168266461 1.8348825775804072 0.0665230896575184 1.0 0.3462065547937145 8 Q9BUB5,P27361,P06730,P46734,Q02750,Q96KB5 6 |
| Il17 signaling pathway 0.6839933993399144 1.824890811911679 0.0680175080251326 1.0 0.3462065547937145 7 P40763,Q04206,O43318,P27361,O14920,P49841 6 |
| Neuroinflammation 0.7243862947267399 1.8181579556303933 0.0690399940580255 1.0 0.3462065547937145 6 Q16539,Q04206,O15111 3 |
| Kit receptor signaling pathway 0.5053257520463496 1.815308091843898 0.0694765761664744 1.0 0.3462065547937145 19 Q16539,Q06124,P51812,P22681,P19174,Q15418 6 |
| Pentose phosphate pathway in senescent cells 0.7222171608501378 1.808332930143831 0.0705546996374772 1.0 0.3462065547937145 6 O95336 1 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.6803070785773894 1.8071702462054628 0.0707357385916123 1.0 0.3462065547937145 7 P48507,P48506,Q14145 3 |
| Cytosolic dnasensing pathway 0.51758097399007 1.805835963118979 0.0709439661462529 1.0 0.3462065547937145 17 Q04206,O15111,Q86UT6,O14920,Q9H1D9,P62875,Q13546,Q14258 8 |
| Pancreatic adenocarcinoma pathway 0.4690510417098422 1.7856518821520015 0.0741556408479253 1.0 0.3555945371150164 23 Q04206,O15111,Q13485,O14920,P11802,P42224,Q00534,P06400 8 |
| Praderwilli and angelman syndrome 0.5705025717374499 1.754878493775338 0.0792800935207249 1.0 0.3555945371150164 11 Q99741,Q15154,P11802 3 |
| Atm signaling pathway 0.5267379016232016 1.7461925004325112 0.0807775075521068 1.0 0.3579031908228882 15 Q13546,O14757,P30307,P14635 4 |
| 16p112 proximal deletion syndrome 0.4480027575089288 1.7450954076244238 0.0809682628418992 1.0 0.3579031908228882 27 Q9BW71,Q16204,Q14738,Q14807,P46734,P49368,Q6IN85,Q12933,P78371,Q9NY27 10 |
| Glycogen synthesis and degradation 0.494211316940996 1.7365109149225038 0.0824735361172379 1.0 0.3596563800247314 19 P63151,P46020,Q14738,P49841,Q16851,Q15257,P11216 7 |
| Tnfalpha signaling pathway 0.4404599318868419 1.72079807825036 0.0852874712784048 1.0 0.3670028776276289 28 O15111,O14733,P42574,O14920,Q13546,O00221,Q12933,Q6GQQ9 8 |
| Mfap5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement 0.6622546992734449 1.7199944151973372 0.0854334567592185 1.0 0.3670028776276289 7 P19174 1 |
| Mirna biogenesis 0.731886574424732 1.7077320005279206 0.0876860815358311 1.0 0.3673978599724512 5 Q9HAV4,P62826 2 |
| Resistin as a regulator of inflammation 0.6162704497366386 1.6996139167922184 0.0892035708917242 1.0 0.3673978599724512 9 Q16539,O15111,P19174,O14920 4 |
| Il2 signaling pathway 0.5818538107096392 1.659010236069307 0.0971137296818591 1.0 0.3851263032115765 10 P40763,P62753,P27361,Q06124,P22681,Q02750,P42224 7 |
| Cardiac hypertrophic response 0.5127475776057128 1.6552652199398432 0.0978707106756404 1.0 0.3851263032115765 15 O15111,O14733,O14920,Q16539,P49841,P46734 6 |
| Il6 signaling pathway 0.5520326791560253 1.646964226428275 0.0995653990883775 1.0 0.3851263032115765 11 P40763,O43318,P28482,P27361,Q06124,P49841,Q02750,P42224 8 |
| Insulin signaling in adipocytes normal condition 0.7757105656975787 1.6456918384567556 0.0998272201956766 1.0 0.3851263032115765 4 O60343 1 |
| Insulin signaling in adipocytes diabetic condition 0.7757105656975787 1.6456918384567556 0.0998272201956766 1.0 0.3851263032115765 4 O60343 1 |
| Tcell activation sarscov2 0.4935796133442995 1.6421542846143335 0.1005580340494067 1.0 0.3851263032115765 17 O15111,O14920,P49841,P49815,P19174,Q9UDY8 6 |
| Parkinsons disease pathway 0.5508434457642808 1.6399870337676925 0.1010078629442978 1.0 0.3851263032115765 11 P42574,Q99700,P68036,Q16539,P55212,P55210 6 |
| 3q29 copy number variation syndrome 0.4926638299778859 1.6358753337725518 0.1018656813231957 1.0 0.3851263032115765 17 O94888,Q8NCM8,P63167,P49023,Q96EB6,Q96EX3 6 |
| Il7 signaling pathway 0.6838053340665297 1.633027760023836 0.1024631583755315 1.0 0.3851263032115765 6 P40763,P27361,P49841,Q02750,P42224 5 |
| Osteopontin signaling 0.6838053340665229 1.6330277600238043 0.1024631583755382 1.0 0.3851263032115765 6 Q04206,O15111,P27361,O14920,Q02750 5 |
| Tlr4 signaling and tolerance 0.6229264414890334 1.6262872367521966 0.1038885656215224 1.0 0.3851263032115765 8 O15111,Q13546,O14920 3 |
| Transsulfuration pathway 0.6420013930947843 1.6214532442891174 0.1049204696687799 1.0 0.3851263032115765 7 P48507,Q99707,P26358,P25325 4 |
| Supression of hmgb1 mediated inflammation by thbd 0.7686177521296826 1.6161236955594112 0.1060675720320407 1.0 0.3851263032115765 4 Q04206,O15111,O14920 3 |
| Interferon type i signaling pathways 0.4763478139432954 1.6090401438291488 0.1076075640114049 1.0 0.3884060002778521 19 P40763,P62753,Q16539,Q06124,Q99873,P46734,P22681,P42224,Q53EL6 9 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.6740792472415806 1.5882749609860165 0.1122241768955274 1.0 0.3993059218821092 6 O15111,P06753 2 |
| Alzheimers disease 0.3430195719747084 1.5856900055993142 0.1128096474539446 1.0 0.3993059218821092 93 Q04206,P17655,P28070,Q9Y277,O00233,P25789,O14654,P45880,O95197,Q00535,Q07866,Q12933,Q9NQC3,O15111,O14733,Q13200,Q9H0B6,Q15008,Q9Y4P8,P42574,P51665,O14920,P49841,Q08752,P60900,Q02750,O00487,Q13564,P14735,P55210,O43242,O00213,P25786 33 |
| Il5 signaling pathway 0.531620623093606 1.5800978661212854 0.1140844559269034 1.0 0.3993059218821092 12 P40763,P62753,P27361,Q06124,P49841,P49840,Q02750,P42224,Q15418 9 |
| Sarscov2 innate immunity evasion and cellspecific immune response 0.5293216768537494 1.566212738105162 0.1172988215901411 1.0 0.4063988216867054 12 Q6PKG0,Q13546,P42224 3 |
| Purine metabolism 0.5631808677774184 1.5551893455033057 0.1199009810476372 1.0 0.4106329773411323 10 P30520,P30566,P00492,P00813,P20839,P00491 6 |
| Transcriptional activation by nrf2 in response to phytochemicals 0.6663657042478665 1.5526899772497722 0.1204972179410863 1.0 0.4106329773411323 6 P48506,Q14145 2 |
| Onecarbon metabolism and related pathways 0.4957575476461003 1.5441573930307813 0.1225502078132412 1.0 0.4153090375893175 15 P34896,P48507,O15382,Q9Y6K0,P48506,P00390,P04818 7 |
| Heart development 0.6929537994648651 1.5360459281754864 0.1245271164322856 1.0 0.4173711045257925 5 Q12948,Q13485 2 |
| Pi3kaktmtor vitd3 signaling 0.6224075782347545 1.5254582005113293 0.1271448517011846 1.0 0.4215128235745793 7 P49815,P49841,P54646 3 |
| Dna replication 0.3912139906429149 1.5149544177336167 0.1297839479270339 1.0 0.4256355281477996 33 Q99741,Q14566,P35244,P28340,P49643,P40938,Q14181,P25205,Q9UBD5 9 |
| Glutathione metabolism 0.616711600831826 1.4974440593057556 0.1342777512002584 1.0 0.4323770824843438 7 P48507,P48506 2 |
| Ferroptosis 0.429139458037779 1.495768517137584 0.1347139882011938 1.0 0.4323770824843438 24 P45880,P48507,Q9BX63,Q15365,P48506,Q9Y277,O95352 7 |
| Genes related to primary cilium development based on crispr 0.4875869647980023 1.4905013614931082 0.1360924587491705 1.0 0.4323770824843438 15 O95684,Q8NCM8,P63167,Q9Y496,Q96EX3 5 |
| Hepatitis c and hepatocellular carcinoma 0.5070737474973834 1.4871736532304032 0.1369689526832331 1.0 0.4329070525221359 13 P40763,Q13485,P42574,P27361,Q16539,Q06124,Q14247,P55210,P38398 9 |
| Interleukin11 signaling pathway 0.4734437728176323 1.4679216326096431 0.1421255113014705 1.0 0.4349497643870001 16 Q04206,O15111,P62753,O14920,Q06124,P42224,Q15257,Q15418 8 |
| Nucleotide excision repair in xeroderma pigmentosum 0.3738077109937403 1.4642487676415803 0.1431259898050867 1.0 0.4349497643870001 37 P41208,Q9NR33,P49916,Q92889,P18074,P18858,P35244,P28340,P40938,P38398 10 |
| Mapk signaling pathway 0.3625803977409104 1.4635406005393217 0.1433195125275197 1.0 0.4349497643870001 52 O15111,O14733,Q9BUB5,P42574,O14920,Q16539,Q8IW41,P51812,Q99956 9 |
| Alzheimers disease and mirna effects 0.3351563200354582 1.4417151377337227 0.149382751395446 1.0 0.4377441389276914 95 Q04206,P17655,P28070,Q9Y277,O00233,P25789,O14654,P45880,O95197,Q00535,Q07866,Q12933,Q9NQC3,O15111,O14733,Q13200,Q9H0B6,Q15008,Q9Y4P8,P42574,P51665,O14920,P49841,Q08752,P60900,Q02750,O00487,Q13564,P14735,P55210,O43242,O00213,P25786 33 |
| Quercetin and nfkb ap1 induced apoptosis 0.937105190881624 1.4401726444455027 0.1498185605854529 1.0 0.4377441389276914 2 Q14145 1 |
| Prolactin signaling pathway 0.4194615117836152 1.4179442969717757 0.1562070282281733 1.0 0.4494636189584233 24 Q04206,P62753,P42574,Q16539,Q06124,P49841,P22681,P49023,P42224 9 |
| Nad metabolism sirtuins and aging 0.7194221785222883 1.4098285307272411 0.1585903199614382 1.0 0.4536103391795673 4 P43490 1 |
| Nrf2are regulation 0.5105523613522116 1.4019110541329405 0.1609418091022574 1.0 0.4566255979180326 11 P48507,P48506,P49841,Q14145 4 |
| Network map of sarscov2 signaling pathway 0.3827668242109281 1.3843831406685616 0.1662411684682616 1.0 0.463046177012053 32 Q96B36,P62753,Q96J02,P42574,Q86VN1,P51617,Q9H269,P42224,O95067,P14635,Q12933,Q6PKG0 12 |
| Erk pathway in huntingtons disease 0.657749391745243 1.3794246610512726 0.167763860053459 1.0 0.4635739418805216 5 O14733 1 |
| Ciliopathies 0.449105557490606 1.3719819678402885 0.1700690513772387 1.0 0.4635739418805216 18 Q8NFG4,Q8TD19,Q8NCM8,Q96EX3 4 |
| Regulation of sister chromatid separation at the metaphaseanaphase transition 0.5299668924297509 1.3690284294577977 0.170990388398553 1.0 0.4635739418805216 10 O60566,O43683,Q12834,Q14674 4 |
| Malignant pleural mesothelioma 0.3065182949437898 1.3664765451775376 0.1717894377809035 1.0 0.4636794559573059 77 P62753,Q9BUB5,Q16539,P51812,P11802,Q99728,Q96B36,P11166,Q15022,P46734,P49815,P42224,Q9HCK8,Q12933,Q15418,O14733,Q9Y4R8,Q13257,P38398,P49841,P54646,P51610,O95816,Q06546 24 |
| Acute viral myocarditis 0.4334899666455143 1.343935983434088 0.1789690888044357 1.0 0.478805454947982 20 P42574,Q9NRG0,P55212,P49841,O76075,P42224 6 |
| Egfegfr signaling pathway 0.3566565248212726 1.341530489637217 0.1797482773493244 1.0 0.478805454947982 47 Q96J02,Q16539,Q06124,P51812,P40818,P22681,P19174,P42224,Q15418 9 |
| Micrornas in cardiomyocyte hypertrophy 0.4187289466024351 1.3322230807287716 0.182786894293458 1.0 0.4847826326913453 22 P40763,O15111,O14733,P27361,O14920,Q16539,Q13144,P49841,P46734,P61586,Q02750 11 |
| Nanoparticle triggered autophagic cell death 0.581942987795395 1.3256233538190607 0.1849644866649722 1.0 0.4884343587256842 7 Q9NT62,O95352 2 |
| Energy metabolism 0.4775508694270715 1.3028588118293805 0.192622967863159 1.0 0.4965444299833331 13 Q16539,Q99873,P49841,P54646,Q8WVM0,Q96EB6,Q06546 7 |
| Proteasome degradation 0.3562295019808554 1.294330898810011 0.1955511479402656 1.0 0.4991054403496319 40 P61289,P20618,P28070,Q06323,P55036,Q9UL46,O00233,P25789,P62191,P25788,P28066,Q13200,Q15008,O75832,P51665,P60900,O14818,O43242,P25786 19 |
| Vasopressinregulated water reabsorption 0.4392466592973845 1.2669076886669224 0.2051882991980398 1.0 0.5083664541216008 17 Q14203,O43237,Q8NCM8,Q9Y6G9,P63167,P52565,Q13561,Q9UJW0 8 |
| Canonical and noncanonical tgfb signaling 0.8926119198022506 1.2656302253273968 0.2056454995845387 1.0 0.5083664541216008 2 Q13485 1 |
| Nucleotide excision repair 0.3908985535159338 1.2638562783706715 0.2062816170506725 1.0 0.5083664541216008 27 P41208,Q9NR33,Q92889,P18074,P18858,P35244,P28340,P40938 8 |
| Serotonin receptor 467 and nr3c signaling 0.6834295136026474 1.2581240207234148 0.2083469074268262 1.0 0.5083664541216008 4 Q02750,P27361,P49137 3 |
| Angiotensin ii receptor type 1 pathway 0.6834295136026085 1.2581240207232507 0.2083469074268855 1.0 0.5083664541216008 4 Q06124,Q13485,P63244 3 |
| Pyrimidine metabolism 0.3475571956276598 1.2530553212801012 0.2101855743636105 1.0 0.5084500146230587 48 P17812,Q9NR33,P23921,P04183,Q7LG56,O76075,Q9BZX2,P49643,P04818,P33316 10 |
| Oxidative stress response 0.5472904199713762 1.2390086945083252 0.2153422782177751 1.0 0.5138898577141251 8 Q16881,P48506,P00390 3 |
| Camkk2 pathway 0.4564597799280202 1.2248974767827323 0.2206138512415303 1.0 0.5163736945436743 14 Q14012,O00429,Q96EB6,Q13501 4 |
| Hypothesized pathways in pathogenesis of cardiovascular disease 0.622966013456802 1.2240318304223794 0.2209402201244246 1.0 0.5163736945436743 5 Q16539,Q13485,P27361 3 |
| Thermogenesis 0.3682419200583876 1.2063055911938143 0.2276996826156199 1.0 0.5281247391464948 31 Q96B36,Q7LBC6,Q16539,P51812,P46734,P54646,O43772,P49815,Q15418 9 |
| Nad metabolism 0.8564814596430363 1.20142646500684 0.2295858152924288 1.0 0.5304823762438696 3 P43490 1 |
| Fibrin complement receptor 3 signaling pathway 0.5871209010193668 1.1840060907764252 0.2364106517916981 1.0 0.542144727792992 6 P51617,O15111,O14920 3 |
| Interactions between loxl4 and oxidative stress pathway 0.661785546464386 1.1669345441303869 0.2432368042681105 1.0 0.5536360097147293 4 Q8TAG9 1 |
| Translation factors 0.3435533186981557 1.162836179983771 0.2448959748852277 1.0 0.5553403147954978 39 Q9NR50,P41567,O60841,P19525,P20042,Q13144,P62495,Q9UI10,P49770,P63241,O43432,P13639,P06730,P26641,P11940,Q04637,O00303,Q14232,Q9H074,Q14152 20 |
| Caloric restriction and aging 0.6570166729263172 1.1468729449393067 0.2514341358542937 1.0 0.5618439044192377 4 P43490 1 |
| Mapk and nfkb signaling pathways inhibited by yersinia yopj 0.8398052751571239 1.1398035254131025 0.2543681646666618 1.0 0.5618439044192377 3 O15111 1 |
| Cardiac progenitor differentiation 0.8382546337742774 1.1340863916003487 0.2567583113185661 1.0 0.5618439044192377 3 Q16539 1 |
| Transsulfuration and onecarbon metabolism 0.4082775278229449 1.1186889586266588 0.2632728572367608 1.0 0.5618439044192377 19 P31153,P23526,P34896,P48507,P26358,Q6UB35,P48506,O43865,Q9NZL9,Q99707,P04818,O43175 12 |
| Bmp signaling in eyelid development 0.8335491851519705 1.1167530638831746 0.2640999223739153 1.0 0.5618439044192377 3 Q12948 1 |
| Embryonic stem cell pluripotency pathways 0.4477577297759186 1.116576988398416 0.2641752352450148 1.0 0.5618439044192377 13 Q06124,P46734,Q13485,P49841 4 |
| Glioblastoma signaling pathways 0.3764940787779983 1.1161850049138722 0.2643429517513462 1.0 0.5618439044192377 26 O14733,P46734,P49815,P22681,P11802,P19174,Q00534,P06400,P38398 9 |
| Gastrin signaling pathway 0.3483563863533912 1.1082549164911522 0.2677517398571536 1.0 0.5654757821376262 33 Q04206,O15111,P62753,P42574,O14920,Q16539,Q06124,P49841,P49023,P19174 10 |
| Pdgf pathway 0.4292710502063999 1.1059235229632185 0.2687596223594748 1.0 0.5654757821376262 15 P40763,O15111,P27361,Q06124,P61586,Q02750,P19174,P42224 8 |
| Nucleotidebinding oligomerization domain nod pathway 0.4532048046937555 1.1029547954947585 0.2700467964642974 1.0 0.5654757821376262 12 Q04206,O15111,O14920,Q9Y2Z0,Q7L5N1 5 |
| Phosphoinositides metabolism 0.459070099324729 1.0954260693972906 0.2733300182310092 1.0 0.5671133031323661 11 P19174 1 |
| Photodynamic therapyinduced nfkb survival signaling 0.8244505494505499 1.083308429020354 0.2786715451993009 1.0 0.5723556988941871 3 O15111,O14920 2 |
| Altered glycosylation of muc1 in tumor microenvironment 0.8244505494505499 1.083308429020354 0.2786715451993009 1.0 0.5723556988941871 3 O15111,O14920 2 |
| Clear cell renal cell carcinoma pathways 0.3330067609523333 1.058213288539717 0.2899582143087558 1.0 0.5914403375334698 40 P40763,Q96B36,P11166,P34896,Q13501,Q14012,P49815,P53396 8 |
| Exrna mechanism of action and biogenesis 0.6329416816001289 1.0459065234185538 0.2956041922318686 1.0 0.5972887930825809 4 Q9HAV4 1 |
| Mevalonate pathway 0.557417113427745 1.04568409019565 0.2957069106736711 1.0 0.5972887930825809 6 P04035,P53602,Q01581,Q9BWD1 4 |
| Netrinunc5b signaling pathway 0.4175234147848362 1.0288432126568634 0.3035533569130368 1.0 0.6031516212278583 15 Q06124,P42574,Q8TCG1,Q15257 4 |
| Hereditary leiomyomatosis and renal cell carcinoma pathway 0.4405698200730417 1.0262431617228542 0.3047769812186971 1.0 0.6036167485175494 12 Q13618,P62753,Q14145 3 |
| Methionine metabolism leading to sulfur amino acids and related disorders 0.625637335797072 1.0154147913369318 0.3099081452021126 1.0 0.6078584198498029 4 Q99707,P55263 2 |
| Nitric oxide metabolism in cystic fibrosis 0.5484236420434782 1.0039909524249977 0.3153829745905085 1.0 0.6135208241224075 6 Q99873,O60678,Q86X55 3 |
| Aryl hydrocarbon receptor pathway wp2586 0.4367851369969494 1.0033404546875202 0.3156966234395759 1.0 0.6135208241224075 12 P48506,O00170,P06400 3 |
| Translation inhibitors in chronically activated pdgfra cells 0.3814776096072027 1.001188837165919 0.3167355222674934 1.0 0.6135208241224075 21 P62753,O14733,P27361,P06730,Q16539,P46734,Q04637,Q02750,O43432,Q53EL6,Q15418 11 |
| Apoe and mir146 in inflammation and atherosclerosis 0.8242241142543234 1.0010179498155325 0.3168181304894399 1.0 0.6135208241224075 2 P51617 1 |
| Molybdenum cofactor moco biosynthesis 0.7955076787347297 0.9777070593322682 0.3282192293186599 1.0 0.6276292472864655 3 Q9NQX3 1 |
| Aryl hydrocarbon receptor pathway wp2873 0.5399717102264081 0.9649333541176583 0.3345781939408632 1.0 0.6318659390214445 6 O00170 1 |
| Onecarbon metabolism 0.3923217181632079 0.943803265619994 0.3452701915272973 1.0 0.6441122608790614 17 P34896,P23526,P35754,Q9UBK8,P26358,Q6UB35,Q99707,P04818 8 |
| Ncrnas involved in stat3 signaling in hepatocellular carcinoma 0.8069211755012352 0.9354410810918906 0.349561033990206 1.0 0.6442563189958963 2 Q04206 1 |
| Leptininsulin signaling overlap 0.8069211755012315 0.935441081091879 0.349561033990212 1.0 0.6442563189958963 2 O14654 1 |
| Nephrogenesis 0.8060972260368025 0.9323377445797484 0.3511620072077406 1.0 0.6442563189958963 2 Q04721 1 |
| Fluoropyrimidine activity 0.402545736121334 0.93129578694893 0.3517005806977598 1.0 0.6442563189958963 15 P04183,P04818,P23921 3 |
| Mbdnf and probdnf regulation of gaba neurotransmission 0.501101855508913 0.9255852406680012 0.3546615665054098 1.0 0.6446929115664856 7 P40763,P19174 2 |
| Fgfr3 signaling in chondrocyte proliferation and terminal differentiation 0.5004633696843832 0.922459651695468 0.356288867130754 1.0 0.6446929115664856 7 P28482,P27361,Q16539,Q02750,P42224 5 |
| Androgen receptor signaling pathway 0.3187144712539729 0.9174249236742088 0.3589200173222699 1.0 0.6446929115664856 35 P06400,Q04206,Q86X55,Q13485,P62826,P49841,P60981,Q96EB6,Q5VUA4,P38398,Q8N2W9,Q9UBS8 12 |
| Physicochemical features and toxicityassociated pathways 0.3791154356630966 0.9109275651695296 0.3623335405614076 1.0 0.6446929115664856 19 P07737,P49841,Q14012,P22681,P19174 5 |
| Sphingolipid metabolism in senescence 0.4070472787171194 0.909852649808304 0.3629002239605992 1.0 0.6446929115664856 14 O15121 1 |
| Cytosine methylation 0.5502687437696068 0.9015173864112002 0.3673132938532737 1.0 0.6457092485605099 5 P48735,P26358 2 |
| Myometrial relaxation and contraction pathways 0.3514398346918583 0.8917817310938134 0.3725099356558452 1.0 0.6510918646133684 25 Q99439,P19174,Q06546 3 |
| Cysteine and methionine catabolism 0.5224942098200834 0.8846729726039474 0.3763330367674407 1.0 0.653553188526638 6 Q99707,P48506,P25325 3 |
| Interleukin1 induced activation of nfkb 0.7692573136968572 0.8833138167240491 0.3770667406952359 1.0 0.653553188526638 3 Q13501 1 |
| Canonical and noncanonical notch signaling 0.7685625110864405 0.8808376216937318 0.3784057137237067 1.0 0.653553188526638 3 O15111 1 |
| Apoptosis modulation by hsp70 0.4918032582551015 0.8801790086198437 0.3787623432200648 1.0 0.653553188526638 7 P55212,Q13546,P42574 3 |
| 15q112 copy number variation syndrome 0.5434304562946529 0.8716803852213978 0.3833827637613165 1.0 0.655770216415314 5 Q96RT8,Q06787,Q9BSJ2,Q7L576 4 |
| Mesodermal commitment pathway 0.3438385031000401 0.8709401523202633 0.3837868315742083 1.0 0.655770216415314 27 Q8IWS0,Q16204,Q13485,Q12948,P00492,Q86XI2 6 |
| Cohesin complex cornelia de lange syndrome 0.3769300484850064 0.8658936545473107 0.386548483210738 1.0 0.6586440635713692 18 Q7Z5K2,Q14738,Q14674 3 |
| Cancer immunotherapy by pd1 blockade 0.7595588299132154 0.8488676392159469 0.395954947552267 1.0 0.6690651468334706 3 Q06124 1 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.4358823196808581 0.8418233704720117 0.3998868283586634 1.0 0.6738424455767533 10 Q96B36,P49841,P49770 3 |
| Nonsmall cell lung cancer 0.364220987409672 0.8382891204601887 0.4018683446642384 1.0 0.675315951088665 20 P42574,P11802,P19174,Q00534,Q9HC35,P06400 6 |
| Cell differentiation expanded index 0.7786322438890401 0.8300814093921796 0.4064927572392898 1.0 0.6812103898790296 2 P40763 1 |
| Chromosomal and microsatellite instability in colorectal cancer 0.3665729299577305 0.8232614296892105 0.410359342328324 1.0 0.6858060241651444 19 Q13485,P27361,P42574,P20585,P49841,P61586,P52701,P43246,Q02750,Q96KP1 10 |
| Angiogenesis 0.5736931365924851 0.8019133622941861 0.422603076059945 1.0 0.700510533686322 4 P19174 1 |
| Myd88 distinct inputoutput pathway 0.7662730019225448 0.7849295263324825 0.4324948892683822 1.0 0.7130321147397652 2 P51617 1 |
| Nodlike receptor nlr signaling pathway 0.5222300017809522 0.7801691537696729 0.4352913161295477 1.0 0.7157080939057254 5 Q04206,O15111,O14920 3 |
| Hif1a and pparg regulation of glycolysis 0.5672481886609068 0.7759968409183542 0.437750851131365 1.0 0.7178172558874535 4 P11166 1 |
| 16p112 distal deletion syndrome 0.441221932714682 0.7709122034190761 0.4407589732533923 1.0 0.7208122618889258 9 Q9H5N1,Q99873,Q12933,Q8NCF5,Q8WWM7 5 |
| Apoptosis modulation and signaling 0.3542308316015643 0.7385279964999187 0.4601936608214014 1.0 0.7426405637594045 19 O76075,Q13546,P42574,O14920 4 |
| Rac1pak1p38mmp2 pathway 0.3383985097246176 0.7231647292090198 0.4695786853353927 1.0 0.751779390470606 22 Q04206,O15111,O14920,Q16539,Q06124,P43246,P49023 7 |
| Tgfbeta receptor signaling 0.5083360704599199 0.7212000549961934 0.4707864379668385 1.0 0.751779390470606 5 Q13485,P42224 2 |
| Tgfbeta receptor signaling in skeletal dysplasias 0.5083360704599199 0.7212000549961934 0.4707864379668385 1.0 0.751779390470606 5 Q13485,P42224 2 |
| Il10 antiinflammatory signaling pathway 0.507114102944532 0.7160585471868399 0.4739551983436878 1.0 0.7524088360456435 5 P40763,P42224,P30043 3 |
| Thymic stromal lymphopoietin tslp signaling pathway 0.3744503832887657 0.7085861106153429 0.4785813580093601 1.0 0.7524088360456435 14 P40763,Q04206,P62753,P27361,Q16539,Q06124,Q02750,P42224 8 |
| Nuclear receptors metapathway 0.2888221615464403 0.6911803589230489 0.4894522052906138 1.0 0.7579097527690306 55 Q14145,Q13501,Q16881,P48507,Q15185,P48506,O00170,P11802,P00390 9 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.3774457874338228 0.6879108521866742 0.491508922185387 1.0 0.7579097527690306 13 P49815,P49841,Q15334 3 |
| Il9 signaling pathway 0.4477147141810165 0.6696341969789272 0.5030910087801583 1.0 0.7653005370471236 7 P40763,P28482,P27361,Q02750,P42224 5 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.4181477140844162 0.6536971064682566 0.5133069678213418 1.0 0.7769658818139417 9 Q04206,Q8WX92,P18615,Q9H3P2,Q13547 5 |
| Nanomaterial induced apoptosis 0.4433418635507916 0.6493394086180039 0.516119018718983 1.0 0.7790803802952754 7 P55210,P55212,P42574 3 |
| Mapk cascade 0.4165257433892579 0.645604586563545 0.5185354662293145 1.0 0.7790803802952754 9 O14733,P27361,Q16539,P46734,Q02750 5 |
| Photodynamic therapyinduced ap1 survival signaling 0.4151552416097579 0.6387838467380071 0.5229635580331089 1.0 0.7792761919429577 9 Q16539,O14733,P46734,Q12933 4 |
| Type ii interferon signaling ifng 0.5293079621668266 0.6273082474449061 0.5304571982588768 1.0 0.7834839974283653 4 Q06124 1 |
| Folatealcohol and cancer pathway hypotheses 0.6896409161235295 0.6104000787500253 0.5415968159992504 1.0 0.78808082192538 3 Q99707 1 |
| Il18 signaling pathway 0.2720832198913877 0.6095328051630654 0.542171335235629 1.0 0.78808082192538 63 O15111,O14733,P42574,O14920,Q7L2J0,O00221,P39687,P19174,O95067,P11216 10 |
| Mitochondrial gene expression 0.4596023987125252 0.6058108368608993 0.5446403727492553 1.0 0.78808082192538 6 O00411,Q06546,P51610 3 |
| Thyroid stimulating hormone tsh signaling pathway 0.3217342470463649 0.6052319849327968 0.5450248663926021 1.0 0.78808082192538 22 P27695,P62753,Q16539,P46734,P11802,P42224,P06400,Q15418 8 |
| Estrogen signaling pathway 0.4208077698059053 0.6030298492388848 0.5464888322531734 1.0 0.78808082192538 8 O15111,O14920 2 |
| Tca cycle nutrient use and invasiveness of ovarian cancer 0.6832417582417594 0.5896873644345588 0.5554002679718362 1.0 0.7884036778562307 3 P40763,P27361 2 |
| Neovascularisation processes 0.6832417582417593 0.5896873644345582 0.5554002679718366 1.0 0.7884036778562307 3 Q04206,P27361 2 |
| Heme biosynthesis 0.455670536379552 0.5891510214616881 0.5557599696363593 1.0 0.7884036778562307 6 P08397,P13196,P06132 3 |
| Fragile x syndrome 0.2795880989820923 0.569049798096718 0.5693223456910392 1.0 0.7983600709690435 51 Q96B36,Q9BUB5,Q15334,Q9Y4R8,Q06124,Q9NQX3,Q14012,P49815,P19174 9 |
| P53 transcriptional gene network 0.3828434003655325 0.5605098543579549 0.5751317199922001 1.0 0.8046567642092708 10 Q9NQ88,P43246,Q7LG56 3 |
| Mapk pathway in congenital thyroid cancer 0.7003570447679172 0.5566298351258087 0.577780364997369 1.0 0.8059634337671758 2 Q02750 1 |
| Hijack of ubiquitination by sarscov2 0.4460933133622695 0.5490876704308587 0.5829452861513216 1.0 0.8081741467097867 6 Q15369,Q13564 2 |
| Gammaglutamyl cycle for the biosynthesis and degradation of glutathione including diseases 0.6660109858219834 0.5350926700106844 0.5925857783122077 1.0 0.8178220017430922 3 P48506 1 |
| Gpcrs class a rhodopsinlike 0.6882724526229017 0.5176700733731544 0.6046884817323734 1.0 0.8249715260642346 2 Q9UK39 1 |
| Regucalcin in proximal tubule epithelial kidney cells 0.4015148679112311 0.5137501654420881 0.6074266738192622 1.0 0.8249715260642346 8 Q13485,P42574 2 |
| Ltf danger signal response pathway 0.6830541060148247 0.5011816604841773 0.61624328002634 1.0 0.8298198693511422 2 P51617 1 |
| Hematopoietic stem cell gene regulation by gabp alphabeta complex 0.4532407972343635 0.4990005117086412 0.6177790235603955 1.0 0.8300555162375358 5 Q13485,Q06546 2 |
| Erbb signaling pathway 0.3056454252104448 0.496991579724395 0.6191949891868271 1.0 0.8301295459427792 22 P22681,P19174 2 |
| Osteoblast differentiation and related diseases 0.3339604202828172 0.4754353770832552 0.6344766839387579 1.0 0.8487517043917594 14 Q16539,Q13485,P42224 3 |
| Notch signaling 0.3637523493627632 0.4663322040766256 0.6409777308214808 1.0 0.855385198911924 10 Q8TDB6 1 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.3172154637369027 0.4638525886810191 0.6427533628709157 1.0 0.855385198911924 17 Q9UPY3,P49841,P11802,P42166 4 |
| Epithelial to mesenchymal transition in colorectal cancer 0.2937430547183835 0.4626122792783192 0.6436423054107756 1.0 0.855385198911924 25 Q13485,P27361,Q15022,Q15910,Q16539,Q16625,P49841,P46734,Q9Y3F4,Q04721,Q02750,P15924 12 |
| Striated muscle contraction pathway 0.3994751994426337 0.4547564679391128 0.6492844514443947 1.0 0.8591961279230618 7 Q8WZ42,P06753,P28289 3 |
| Methionine de novo and salvage pathway 0.3882447065939343 0.4546974581601966 0.6493269097910352 1.0 0.8591961279230618 8 P31153,P23526,Q9BV20,Q99707,P19623 5 |
| Burn wound healing 0.3716794254522935 0.4325545342501709 0.6653384257282278 1.0 0.8740202124605048 9 Q99439,P42574 2 |
| Thyroid hormones production and peripheral downstream signaling effects 0.2992915546560399 0.431713446262927 0.6659496934342548 1.0 0.8740202124605048 21 Q96B36,Q7LBC6,Q16539,P49815,O60343 5 |
| Apoptosisrelated network due to altered notch3 in ovarian cancer 0.3134435877217695 0.4296649327481979 0.667439395778922 1.0 0.8740202124605048 16 P48506,Q13501 2 |
| Regulatory circuits of the stat3 signaling pathway 0.3343828582143972 0.4232424250854532 0.6721183962577042 1.0 0.8760517558059819 12 Q96B36 1 |
| Interactome of polycomb repressive complex 2 prc2 0.3371661126402682 0.4148926001894825 0.6782205271120607 1.0 0.878622127874684 11 P55199,Q14149,Q15022,Q15910 4 |
| Target of rapamycin tor signaling 0.3277815899560626 0.414631736318025 0.6784115118507805 1.0 0.878622127874684 13 Q96B36,P49815 2 |
| Met in type 1 papillary renal cell carcinoma 0.2914983954783844 0.4076713064294172 0.6835150059428132 1.0 0.8814908198047722 22 Q06124,P22681,P19174 3 |
| Oxysterols derived from cholesterol 0.3864470149976793 0.4009827524838848 0.6884328223574241 1.0 0.884092677132692 7 Q9Y305,O14975,O00154 3 |
| Id signaling pathway 0.6152192752706707 0.3860186575502751 0.6994828510004685 1.0 0.8896726584897512 3 P06400 1 |
| Serine metabolism 0.4034026736322124 0.3814423393419698 0.7028750491932689 1.0 0.8913800000164118 6 P04818 1 |
| T cell receptor and costimulatory signaling 0.3987525894225724 0.3644748597903527 0.7155034436423491 1.0 0.9014766039475044 6 P19174 1 |
| Agerage pathway 0.2824767699899646 0.3541398147702166 0.7232341051784259 1.0 0.9077629715202464 22 Q04206,O15111,P42574,O14920,Q16539,P42224 6 |
| Physiological and pathological hypertrophy of the heart 0.355693405310761 0.3201785612765674 0.7488329740720086 1.0 0.9165369097315728 8 P40763,P61586,P46734,Q16539 4 |
| Hair follicle development cytodifferentiation part 3 of 3 0.3804151142221587 0.3005303203114234 0.7637726724076215 1.0 0.9198832425886762 6 Q13485 1 |
| Breast cancer pathway 0.265654789241002 0.288333447252051 0.773091506573846 1.0 0.92527398964766 25 P49841,Q04721,P11802,Q00534,P38398 5 |
| Integrinmediated cell adhesion 0.2608127210838399 0.2810955745355851 0.778637095394757 1.0 0.9276731019351596 28 P17655,P49023,P46734 3 |
| Serotonin receptor 2 and elksrfgata4 signaling 0.3843554324351221 0.2634727524630335 0.7921862222223679 1.0 0.938317661273096 5 Q02750,P27361,P49137 3 |
| Amyotrophic lateral sclerosis als 0.3124157570693371 0.2440308414980436 0.8072069337869863 1.0 0.9443734770252808 10 Q16539,P42574 2 |
| Copper homeostasis 0.3109308851873359 0.2384427095192581 0.8115377450814008 1.0 0.9443734770252808 10 Q9Y6N1,P42574,P49841 3 |
| Pi3kakt signaling pathway 0.2411166162064301 0.236912403344117 0.8127247474068584 1.0 0.9443734770252808 46 P63151,Q04206,O15111,P62753,Q14738,O14920,P49841,P54646,P49815,P11802,Q00534,P38398 12 |
| Transcription cofactors ski and skil protein partners 0.3743815283122559 0.2348320158118008 0.8143391174548247 1.0 0.9443734770252808 5 O14744,Q13547,P21359,P51608 4 |
| Nongenomic actions of 125 dihydroxyvitamin d3 0.2925070307131653 0.2343085146076696 0.8147454761935438 1.0 0.9443734770252808 12 P27361,P28702,O14920,Q16539,Q13555,P42224 6 |
| Lncrna in canonical wnt signaling and colorectal cancer 0.2774406323569297 0.2273447394497477 0.8201556867047328 1.0 0.9443734770252808 15 Q9HCK8,O43318,P49841,Q00534 4 |
| Pdgfrbeta pathway 0.3206273804272082 0.2269986236005987 0.8204248124431159 1.0 0.9443734770252808 9 P40763,Q02750,P19174,P42224 4 |
| Notch signaling pathway 0.2704878564662501 0.2199036592898486 0.8259461863679216 1.0 0.9477888221375166 16 P40763,Q96J02,P49841,Q04721 4 |
| Mecp2 and associated rett syndrome 0.2533446757431277 0.2187215033183977 0.8268669973026368 1.0 0.9477888221375166 23 P62753,Q15910,P52597,O75376,P49711,Q13451,Q05086,P21359,P67809,P31943,Q13547 11 |
| Adipogenesis 0.2692840141257369 0.2149112420238405 0.8298365198136244 1.0 0.9479405937945896 16 O14654,P42224,P14174,P06400,P43490 5 |
| Ras signaling 0.233619760681573 0.2023195678248258 0.8396669033735917 1.0 0.9502215600976948 37 Q7Z569,O15111,P19174,O14920 4 |
| Biomarkers for urea cycle disorders 0.5674265311727473 0.2019280615667169 0.8399729639741091 1.0 0.9502215600976948 2 Q14353 1 |
| Ampactivated protein kinase ampk signaling 0.2638872752302582 0.1988175497107987 0.842405467358331 1.0 0.9502215600976948 17 P49815,P14635 2 |
| Extracellular vesicles in the crosstalk of cardiac cells 0.5302829455722393 0.1887877952872282 0.8502591377853888 1.0 0.9538205420491956 3 P40763 1 |
| Nocgmppkg mediated neuroprotection 0.3242019045216803 0.18108405325977 0.8563016013243079 1.0 0.9566739501974868 7 Q04206,Q13555,P98170,Q15334 4 |
| Ethanol effects on histone modifications 0.2804516234039792 0.1764071818502726 0.859974062845041 1.0 0.9590204357138484 11 Q99707,O14929,P04818,P23526 4 |
| Dual hijack model of vif in hiv infection 0.3823066473320168 0.1705931951453993 0.864543648977611 1.0 0.9623569815261728 4 Q93034 1 |
| Leukocyteintrinsic hippo pathway functions 0.3015960374243192 0.1643698337787158 0.8694400097195654 1.0 0.964803783409663 9 Q92597,Q16539,P51153,P27348,P61586,Q96GC9,Q13043,P63000 8 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.3162208264205596 0.1582477397969453 0.8742615867334924 1.0 0.9675526129824594 7 P49815 1 |
| Ovarian infertility 0.4994611360302232 0.1365772045800098 0.8913649957412675 1.0 0.9766129066512808 3 P11802 1 |
| Foxa2 pathway 0.3641110195108679 0.1340530073252642 0.8933606588711716 1.0 0.9766129066512808 4 P49327,P28161,Q13085 3 |
| Nonhomologous end joining 0.3256584262317335 0.1193173652909104 0.9050239262660816 1.0 0.9822371100829572 5 Q14191,Q13426 2 |
| Mthfr deficiency 0.2742343181603179 0.1187125410745547 0.905503100471594 1.0 0.9822371100829572 10 P42574 1 |
| Riboflavin and coq disorders 0.3139176999462543 0.1163674754957112 0.907361311034157 1.0 0.9822371100829572 6 Q86YH6 1 |
| Wnt signaling pathway 0.2383423904799638 0.1059003140629203 0.9156614448841474 1.0 0.9822371100829572 16 O43318,P49841,P61586,P49840,P49815,Q00534 6 |
| Map3k1 role in promoting and blocking gonadal determination 0.3184816066417835 0.1059000439851632 0.9156616591700528 1.0 0.9822371100829572 5 P49841,P61586 2 |
| Fas ligand pathway and stress induction of heat shock proteins 0.2295283531897262 0.1020779209972945 0.9186948259487796 1.0 0.9822371100829572 21 O43318,P42574,P55212,O76075,P55210,Q16644,P06400 7 |
| Vitamin b12 disorders 0.344274331471315 0.1002084175718873 0.9201788633992064 1.0 0.9822371100829572 4 Q99707 1 |
| Ciliary landscape 0.2403002410192767 0.0985918865481766 0.9214623122309408 1.0 0.9822371100829572 115 P06400,Q8TEB1,Q9H4A3,Q14566,Q8TD19,Q9UN37,O95292,Q8TAG9,Q9Y266,Q9UL63,O43805,P43246,Q99567,Q6NTF9,Q9C0C2,Q96EX3,Q9Y312,O95400,P07197,Q96S59,Q7L5N1,O60343,Q9UPT5,P51665,Q8IVV7,Q9H7D7,Q7L590,Q9ULA0,Q9Y6G9,P63167,Q96KP1,P25205,P60660 33 |
| Exerciseinduced circadian regulation 0.243705191170782 0.0966375863762305 0.9230142065598264 1.0 0.9822371100829572 14 Q9P0L0,Q16851,P21266,Q13907,P25789,Q00577 6 |
| Glucuronidation 0.3008321911965282 0.0901069737781425 0.9282022074925232 1.0 0.9822371100829572 6 O95394 1 |
| Melanoma 0.2307149705300969 0.0849260996840099 0.9323201421934956 1.0 0.9822371100829572 16 P11802 1 |
| Genes controlling nephrogenesis 0.2651288866241142 0.0697857304352713 0.944364204949047 1.0 0.9897975343967677 9 Q12948 1 |
| Nipbl role in dna damage cornelia de lange syndrome 0.3099752679307628 0.0560278881619188 0.955319590509394 1.0 0.9978509421416614 4 Q13535,Q13185,Q6KC79 3 |
| Prion disease pathway 0.2509582083243271 0.0423614966307828 0.9662105220173172 1.0 1.0 9 P49711,P42574 2 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.2141675854465294 0.039378777823447 0.9685883996271564 1.0 1.0 15 P05198,P20042,P55010,O15372,O15371,P41567,O75821,P41091,Q14152,O75822,Q13347,O00303,P55884,P60228 14 |
| Envelope proteins and their potential roles in edmd physiopathology 0.2056537254403533 0.0376275539187923 0.9699846386234168 1.0 1.0 20 P42166 1 |
| G13 signaling pathway 0.2082296754841177 0.0364245562137931 0.970943834141363 1.0 1.0 16 P07737,P23528,P61586,Q14344,O60610 5 |
| Ras and bradykinin pathways in covid19 0.2855179994504168 0.0346304002300434 0.9723744601544476 1.0 1.0 4 P28482,Q13464,P61586 3 |
| Epo receptor signaling 0.2482318270256173 0.0282686694127408 0.9774478687955548 1.0 1.0 8 P40763,Q02750,P27361,P42224 4 |
| Type 2 papillary renal cell carcinoma 0.2447744774477535 0.0167844393382717 0.986608583759049 1.0 1.0 7 P11166,Q15370,P23246,Q15369,Q13617,O60610 6 |
| Ncrnas involved in wnt signaling in hepatocellular carcinoma 0.2121159610547551 0.014386132620807 0.9885219228122566 1.0 1.0 11 Q9HCK8,P49841 2 |
| Sleep regulation 0.2463076289136232 0.0143350065223549 0.9885627113308186 1.0 1.0 4 P00813 1 |
| Methylation pathways 0.3087912087912109 0.0133731381062162 0.9893300976122006 1.0 1.0 3 P31153,Q9NZL9 2 |
| Tgfbeta signaling pathway 0.1902232109359511 0.006591078697251 0.9947411181447908 1.0 1.0 40 Q96J02,Q13485,Q16539,P46734,Q9Y3F4,Q96PU5,Q7Z3T8,O95067 8 |
| Endoderm differentiation 0.1856366583609326 0.0004086882660322 0.999673913951429 1.0 1.0 37 Q8IWS0,Q13485,Q86VP6,Q15910,P00492,P46734,Q86XI2,P42224,O14981 9 |
|
|
